Atrioventricular (A-V) conduction, ventriculo-atrial conduction and mechanism of tachycardia were studied by programmed electrical stimulation before and after the administration of ouabain in 15 patients suffering from paroxysmal supraventricular re-entrant tachycardia. In 13 patients the tachycardia circuit was confined to the A-V node. In two patients the stimulation study showed that an accessory pathway was used in a ventriculo-atrial direction during tachycardia. Ouabain lengthened the effective and functional refractory period of the A-V node and A-V nodal transmission time in all patients in whom this could be studied. Only six patients showed lengthening in ventriculo-atrial conduction time or refractory period of the ventriculo-atrial conduction system. In seven patients no tachycardia could be initiated after ouabain. The width of the zone of atrial premature beats able to initiate tachycardia (the tachycardia zone) narrowed in five patients, showed no change in two patients, and increased in one patient. In these eight patients the tachycardia zone shifted to longer premature beat intervals. Ouabain resulted in slowing of cardiac rate during tachycardia. Both patients who used an accessory pathway during tachycardia showed no change in width of their tachycardia zone following ouabain administration. Seven patients were restudied two weeks after chronic oral administration of digoxin. The results were similar to those obtained following ouabain administration. This indicates that in patients suffering from paroxysmal A-V nodal tachycardia the effect of chronic oral digoxin administration can be predicted from the study of the effect of ouabain during programmed stimulation of the heart.
PATIENTS IN WHOM TACHYCARDIAS can
be reproducibly initiated by programmed electrical stimulation of the heart are most suitable for the study of the effects of drugs on the arrhythmia. By using programmed electrical stimulation the acute action of different drugs has been evaluated in patients with the Wolff-Parkinson-White syndrome1-5 and A-V nodal tachycardia."
This article reports on the effect of both acute and chronic administration of digitalis in patients thought to be suffering from paroxysmal A-V nodal tachycardia.
Material and Methods
Fifteen patients were studied. All suffered from recurrent attacks of (electrocardiographically documented) supraventricular tachycardia. During sinus rhythm and tachycardia 12 patients showed a normal QRS, two showed complete right bundle branch block and one complete left bundle branch block. None of the patients showed electrocardiographic evidence of the Wolff-Parkinson-White syndrome. Eleven patients were female and four male. Their ages ranged from 11 to 73 years. After obtaining informed consent, four catheters were passed through the femoral veins using the Seldinger technique. Two bipolar catheters were positioned high on the lateral wall of the right atrium. One was used for stimulation, the other for recording an intra-atrial electrogram. A tripolar catheter was placed in the region of the bundle of His to record a His bundle electrogram. 7 The fourth (bipolar) catheter was positioned in the apex of the right ventricle and used for ventricular stimulation. In five patients a patent foramen ovale permitted recording of a left atrial electrogram. With help of the single test stimulus method during right atrial stimulation the functional and effective refractory period of the A-V node, the effective refractory period of the atrium and the zone of premature beat intervals resulting in atrial echoes or sustained tachycardia were carefully determined. Thereafter, using the single test stimulus method the right ventricle was paced up to its effective refractory period. The refractory period and pattern of V-A conduction were registered. Both atrial and ventricular pacing were done at rates just above the spontaneous sinus rate. Following these measurements digitalis was administered as ouabain in a dosage that ranged from 0.75 to 1.25 mg according to body weight. The drug was given directly into the right atrium through the catheter used for recording the atrial electrogram. During the hour following termination of the intraatrial injection of ouabain the same stimulation program was repeated at least four times using identical basic cycle lengths and test stimulus intervals. In seven patients the stimulation procedure was repeated three to six weeks later, after taking oral digoxin in the interim. In these patients the digoxin levels at the time of the second catheterization varied from 1.1 to 2.4 ng/ml. In all seven patients the same basic pacing intervals were used as during their first study. Care was taken to place the stimulating and recording electrodes as nearly as possible in the same positions during the first and second catheterization to minimize the effect of 779 varied approaches to the A-V node on A-V nodal function. 8' 9 All data obtained during the stimulation studies were recorded on tape (Ampex FR 1300) and directly registered on an eight channel Elema Mangograf recorder. Leads I, II,   III, V,, V6, the intracavitary right atrial lead, a left atrial lead   if available, and the His bundle lead were all recorded  simultaneously. For recording the His bundle electrogram  an Elema EMT 12 was used. S,, A,, H1, and V1 represent stimulus artifact, atrial, His bundle and ventricular electrograms of the basic atrial or ventricular paced complexes. S2, A2, H2 and V2 represent stimulus artifact, atrial, His bundle and ventricular electrograms of the premature atrial or ventricular beats.
A* represents the atrial electrogram of the atrial echo or atrial activation during tachycardia.
The effective refractory period of the A-V node was defined as the longest A1-A2 interval failing to conduct through the A-V node. The functional refractory period of the A-V node was defined as the shortest attainable H1-H2 interval.
Since it was not consistently possible to determine which part of the V-A conduction pathway became refractory during ventricular pacing, using the single test stimulus method, no values will be given for the effective refractory period of the different parts of this pathway.
The Figure 2 correlates the ERPAVN and FRPAVN following ouabain with those observed following digoxin administration. When A-H intervals measured at the shortest A1-A2 which were conducted to the ventricle were compared following ouabain and digoxin, differences were found varying from 10 to 35 msec.
V-A Conduction
Before Drug Administration All patients showed ventriculoatrial conduction during ventricular pacing. On applying the single test stimulation procedure ten patients showed the emergence of a retrograde His bundle electrogram at a critical test stimulus interval. This made it possible in these patients to divide the V2-A2 interval into a V2-H2 and an H2-A2 interval.
Following premature beats given with increasing prematurity five patterns of V-A conduction could be recognized prior to ouabain administration:
A) No change in V-A conduction time up to the refractory period of the ventricle: one patient. B) At first, no change in V-A conduction time with the His bundle electrogram approaching the atrial electrogram, followed at a critical V1-V2 interval by sudden prolongation of the V-A conduction time which was found to be situated in the H2-A2 interval: two patients ( fig. 3 ). (fig. 4) . During tachycardia all patients showed a low to high sequence of atrial depolarization. Tachycardia could be terminated by critically timed atrial and ventricular stimuli in all patients. Following ouabain administration four different patterns could be observed as far as initiation of tachycardia by single atrial test stimuli was concerned.
A) In seven patients it was no longer possible to initiate tachycardia. An example is given in figures 5 and 6. In six of the seven patients test stimuli given close to the ERP of the A-V node after ouabain were conducted to the ventricle with marked A2-H2 prolongation and followed by single atrial echoes. The interval between H2 and the atrial echo was similar to the H2-A* interval during tachycardia prior to ouabain administration. In two patients the pattern of sudden increase in A2-H2 interval on entering the tachycardia zone ( fig. 5) was no longer present when the atrial echo zone was entered following ouabain ( fig. 6) .
B) Five patients showed narrowing of the tachycardia zone in addition to a shift to longer A1-A2 intervals of premature beats initiating tachycardia. The width of this zone, which measured 50, 50, 60, 90 and 100 msec, was reduced to 20, 30, 20, 50 and 20 msec, respectively. Three patients showed initiation of tachycardia up to the ERP of the A-V node following ouabain. The other two showed a zone of 20 and 40 msec, respectively, between the ERP of the A-V node and the tachycardia zone. Test stimuli given with such an A1-A2 interval that they fell in between the ERP of the A-V node and the tachycardia zone were conducted with marked delay (A2-H2 interval) to the ven-11 _j~-----~-~j _ <, tricle and followed by single atrial echoes but no tachycardia. C) In two patients the tachycardia zone shifted to longer A1-A2 intervals with no significant change in width. In one patient the tachycardia zone moved from A1-A2 intervals of 290 to 350 msec to 320 to 390 msec, in the other patient from A1-A2 intervals of 270 to 360 msec to 350 to 430 msec. The first patient showed the V-A conduction pattern during ventricular pacing shown in figure 3 . The second patient was the one in whom tachycardia could also be initiated by a single ventricular premature beat during ventricular pacing ( fig. 4) . In both patients, following ouabain, the tachycardia zone lasted to the ERP of the A-V node. D) In one patient the tachycardia zone not only shifted to longer A1-A2 intervals but also widened considerably. This is shown in figures 7 and 8. In this patient the tachycardia zone increased by 90 msec. As shown in figures 7 and 8 the sudden increase in A2-H2 interval on entering the tachycardia zone was present both before and after ouabain administration. All patients in whom it was still possible to initiate tachycardia following ouabain administration showed slowing in heart rate during tachycardia. During tachycardia after ouabain A-H intervals were longer but H-A intervals were the same compared to tachycardia before ouabain. This prolongation of A-H without reduction of H-A produced a longer R-R in- Figure 5 Initiation of tachycardia by a single atrial premature beat during atrial pacing at a basic cycle length of 700 msec. Five figure 9 . In two patients ouabain resulted in narrowing of the tachycardia zone. The same was observed after digoxin. In one patient the tachycardia zone which measured 100 msec prior to digitalis, narrowed to 20 msec following ouabain, and became 50 msec after digoxin. One patient who showed a change in tachycardia zone to longer premature beat intervals without a change in width of the tachycardia zone following ouabain had similar findings after digoxin.
Discussion
If vagal maneuvers fail to terminate supraventricular tachycardia digitalis has been advocated as the first drug of choice.'1 As shown by several workers"2-"' using programmed electrical stimulation of the heart, digitalis increases the effective and functional refractory period of the A-V node and slows A-V nodal conduction time.
Our observations demonstrate that these effects can be beneficial in patients suffering from paroxysmal A-V nodal tachycardia, not only for termination but also for prevention of tachycardia. In twelve of our fifteen patients tachycardia could either no longer be initiated or the zone of premature beats able to initiate tachyeardias narrowed considerably. In order to initiate A-V nodal tachycardia by a premature beat, slow conduction through the node is necessary. It has been stated that the ERP of the node should be short enough to allow the premature beat to enter the node early enough to be slowed sufficiently to start reentry.'0 Lengthening of the ERP of the node, thereby preventing the possibility of slow conduction through it, has been described by Wit and Cranefield as the mechanism responsible for prevention of A-V nodal tachycardia following verapamil. of lengthening of the ERP of the node marked slowing in A-V nodal transmission time had occurred. All patients showed maximal A-H intervals which were of the same order or even longer (figs. 5 and 6) compared to those prior to digitalis. The beneficial effect of digitalis can therefore not be explained by lengthening of the ERP of the node alone. In six of the seven patients in whom digitalis prevented the initiation of tachycardia it was still possible to elicit a single atrial echo beat. Most probably, the increase in transmission time through the node in atrioventricular direction resulted from considerable prolongation of the refractory period of the antegrade part of the re-entry pathway. This prevented the impulse that followed the production of the atrial echo from returning to the ventricles and initiating tachycardia. In those patients in whom initiation of tachycardia was still possible after digitalis administration there was slowing of the tachycardia frequency associated with an increase of only the A-H interval. Since Initiation of tachycardia prior to ouabain. When the interval of the test pulse is changed from 370 to 360 msec, there is an increase in A2-H2 interval from 230 msec to 350 msec. This increase in A2-H2 interval is followed by tachycardia. All premature beats given in the interval range 360-300 msec were followed by tachycardia. The ERP of the AV node was 300 msec.
change in the H-A* interval. In terms of the surface ECG none of our patients showed the inverse relation between P-R and R-P interval which is considered suggestive for A-V nodal re-entry. 
prematurity the other patient showed no increase in V-A conduction time, with the H2 approaching A2, up to a critical V,-V2 interval when a sudden increase in H2-A2 interval appeared. This suggested V-A conduction over an accessory pathway with block in this pathway at a critical V,-V2 interval. Following digitalis V-A conduction was only seen over the accessory pathway. The findings in these two patients demonstrate that in the presence of V-A conduction over an accessory pathway digitalis may not have a beneficial effect. This is not surprising because digitalis-induced slowing in A-V nodal conduction will increase the chance for the impulse to find the ventricular end of the accessory pathway excitable, thus favoring V-A conduction over this pathway and initiation of tachycardia.
Anatomically the tachycardia circuit will be larger in the presence of an accessory pathway compared to an intranodal re-entry circuit, increasing the chance for the A-V node to recover and to conduct the impulse in the A-V direction. The effect of digitalis administration in these patients will depend on the interplay between slowing in A-V conduction time on one hand and the increase in length of the effective refractory period of the node on the other hand.
Denes et al.6 in their study on the effect of propranolol on A-V nodal re-entrant tachycardia had the impression that patients showing a sudden increase in A2-H2 interval on entering the tachycardia zone (their "double pathway" cases) reacted more favorably to the drug than patients with a gradual increase in A2-H2 interval (their "reflection" cases). Prior to ouabain eleven of our patients showed a sudden prolongation of their A2-H2 interval on reaching the tachycardia zone. In ten the effect of ouabain was beneficial. In two of the four patients who showed gradual prolongation of the A2-H2 interval evidence could be obtained for V-A conduction over an accessory pathway. In both patients digitalis did not reduce the width of the tachycardia zone. It is of interest that in two patients showing a sudden increase in A2-H2 interval followed by tachycardia, the administration of ouabain prevented initiation of tachycardia but not of single atrial echoes which appeared at a critical A2-H2 interval after a gradual increase in A2-H2 interval (figs. 5 and 6). If one accepts the double pathway theory this might indicate that administration of ouabain resulted in a) complete refractoriness of the "fast" pathway or b) reduction in the differences in length of refractory periods of the two pathways. Studies at the cellular level are needed to clarify these changes.
Of practical importance is our observation of the good correlation between the acute effect of ouabain Circulation, Volume 52, November 1975 and chronic digoxin administration in patients with A-V nodal re-entrant tachycardia. This indicates that in patients suffering from this type of tachycardia the study of the effect of ouabain during the stimulation procedure is of great value for selecting those who will benefit from chronic oral digoxin administration.
Several authors'"-"8 have recently reported on the use of an accessory A-V connection, only conducting in V-A direction, in patients suffering from paroxysmal supraventricular tachycardia. Our study shows that failure to respond to digoxin therapy in patients apparently suffering from A-V nodal tachycardia may be based upon "concealed" V-A conduction over an accessory A-V connection during tachycardia.
